Addition of low-dose tumor necrosis factor-alpha to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma-bearing rats

S (Saske) Hoving, Ann Seynhaeve, Sandra van Tiel, Lex Eggermont, Timo ten Hagen

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)667-674
Number of pages8
JournalAnti-Cancer Drugs
Issue number6
Publication statusPublished - 2005

Research programs

  • EMC MM-03-47-11

Cite this